FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy

South Egypt Cancer Institute

Assiut University

FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy

Research Authors
M Khallaf, AM Abd El Moatmed, SH Shabaan, AH Zaky, AZ Abdalla
Research Member
Amany Mohammed Abdel Moatamed
Salah Mabrouk Khallaf Abd Rabou
Shimaa Hassan Shabaan Hassan
Amen Hamdy Zaki Ali
Ashraf Zeidan Abdalla Ahmed
Research Department
Department of Medical Oncology
Research Date
Research Year
2023
Research Journal
SECI Oncology
Research Publisher
SECI Oncology